The unified social credit code/registration number of Sinopharm Holding Co., Ltd. is 913100074184344p, and the enterprise is in the opening state.
The business scope of Sinopharm Holdings Co., Ltd. is: industrial investment holding, entrusted management and asset reorganization of pharmaceutical enterprises; Chinese patent medicines, Chinese herbal pieces, chemical preparations, chemical raw materials, antibiotics, biochemical drugs, biological products, narcotic drugs, psychotropic drugs and toxic drugs for medical use (suitable for the business scope); the wholesale of medical in-vitro diagnostic reagents, vaccines, protein assimilation preparations and peptide hormones; the third category: injection puncture instruments and medical use. Food sales management (non-physical way), domestic trade (except special license), logistics and distribution and related consulting services, cosmetics, stationery sales and business information consulting services, dealing in the import and export of various commodities and technologies (excluding those restricted or prohibited by the state in the Import and Export Commodity Catalogue). Projects that are subject to approval according to law can only carry out business activities after being approved by relevant departments. In Shanghai, the total registered capital of companies with similar business scope is 1 863,720,000 yuan, and the main capital is concentrated in 64 enterprises with a scale of over 50 million and 1 0,000-50 million. Within the scope of this province, the registered capital of mobile enterprises belongs to the general.
Sinopharm Holdings Limited invested in 75 companies, 1 branch.
Check out more information and materials of Sinopharm Holding Co., Ltd. through Baidu Enterprise Credit.